We hypothesized that the percentage of the CDX2-negative component in the primary CRC would increase during cancer evolution, based on recent studies showing that the loss of CDX2 expression was associated with worse prognosis [16, 18, 19]. Here, CDX2 is linked to colorectal carcinoma.